Another Voice: Lower cost options to the high-cost drugs are within reach

Another Voice: Lower cost options to the high-cost drugs are within reach
While biosimilars aren't yet available in the U.S., patients in Europe and Asia have used them to lower treatment costs by as much as 40 percent. One study projects that the United States could save $ 250 billion over 10 years if just 11 biosimilars … Read more on Buffalo News

Doctors balk at 0K annual cost for a drug
It was a scientific victory, a triumph of a different model of funding drug development, and a boon to patients when Vertex Pharmaceuticals' cystic fibrosis drug, ivacaftor, was approved in early 2012. It was the first drug to treat one of the genetic … Read more on Boston.com (blog)

Americans: don't weigh costs of new treatments
In another case, one drug costs 100 times more than another. The expensive drug is proven to help treat a serious condition. The cheaper drug is not well tested, but many doctors use it because it seems to work. Here, people were asked how they'd feel … Read more on WKZO